Valuation RaySearch Laboratories AB
Stocks
RAY B
SE0000135485
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 232.40 SEK | -0.34% |
|
+12.82% | +1.93% |
| 07-03 | RaySearch Laboratories Lands Order for Oncology Treatment Planning System in South Korea | MT |
| 07-03 | RaySearch receives add-on order from Yonsei Cancer Center | FW |
Company Valuation: RaySearch Laboratories AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,937 | 2,331 | 3,096 | 7,405 | 7,816 | 7,967 | - | - |
| Change | - | 20.35% | 32.79% | 139.2% | 5.56% | 1.93% | - | - |
| Enterprise Value (EV) 1 | 2,397 | 2,727 | 3,281 | 7,414 | 7,804 | 7,877 | 7,702 | 7,469 |
| Change | - | 13.78% | 20.33% | 125.95% | 5.26% | 0.94% | -2.22% | -3.03% |
| P/E | -40.9x | 98.6x | 37.9x | 36.4x | 34.3x | 27.9x | 22.4x | 18.7x |
| PBR | 2.98x | 3.55x | 4.21x | 8.45x | 7.93x | 7.02x | 5.9x | 4.98x |
| PEG | - | -1x | 0x | 0x | 2.9x | 1.1x | 0.9x | 0.9x |
| Capitalization / Revenue | 3.02x | 2.76x | 3.03x | 6.21x | 5.81x | 5.65x | 4.97x | 4.44x |
| EV / Revenue | 3.74x | 3.23x | 3.21x | 6.22x | 5.81x | 5.59x | 4.8x | 4.16x |
| EV / EBITDA | 12.2x | 8.03x | 8.2x | 13.3x | 13.4x | 12x | 10.1x | 8.63x |
| EV / EBIT | -44.8x | 63.9x | 28.6x | 28.5x | 26.7x | 21.3x | 16.8x | 13.6x |
| EV / FCF | 234x | - | - | - | 21.7x | 41.7x | 26.3x | 19.4x |
| FCF Yield | 0.43% | - | - | - | 4.6% | 2.4% | 3.8% | 5.17% |
| Dividend per Share 2 | - | - | 0.7 | 3 | 3 | 4 | 5.18 | 6.23 |
| Rate of return | - | - | 0.78% | 1.39% | 1.32% | 1.72% | 2.23% | 2.68% |
| EPS 2 | -1.38 | 0.69 | 2.38 | 5.94 | 6.65 | 8.32 | 10.37 | 12.45 |
| Distribution rate | - | - | 29.4% | 50.5% | 45.1% | 48.1% | 50% | 50% |
| Net sales 1 | 641.1 | 843.6 | 1,022 | 1,192 | 1,344 | 1,409 | 1,603 | 1,795 |
| EBITDA 1 | 196.7 | 339.7 | 400.1 | 558 | 583.5 | 655 | 762 | 866 |
| EBIT 1 | -53.5 | 42.7 | 114.9 | 260.5 | 292.3 | 370 | 459 | 549 |
| Net income 1 | -47.3 | 23.8 | 81.57 | 203.5 | 227.8 | 285 | 355 | 426 |
| Net Debt 1 | 459.7 | 395.9 | 185.7 | 9.2 | -12.5 | -90 | -265 | -498 |
| Reference price 2 | 56.50 | 68.00 | 90.30 | 216.00 | 228.00 | 232.40 | 232.40 | 232.40 |
| Nbr of stocks (in thousands) | 34,283 | 34,283 | 34,283 | 34,283 | 34,283 | 34,283 | - | - |
| Announcement Date | 2/23/22 | 2/28/23 | 2/23/24 | 2/21/25 | 2/12/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 28.03x | 5.61x | 12.07x | 1.72% | 828M | |
| 30.13x | 6.61x | 14.64x | -.--% | 31.31B | |
| 96.51x | 81.51x | 96.37x | 0.4% | 14.91B | |
| 100.25x | 15.85x | 68.13x | 0.64% | 5.87B | |
| -35.1x | 9.91x | -53.67x | - | 2.41B | |
| -7.61x | 77.65x | -7.87x | - | 2.23B | |
| 55.17x | - | - | -.--% | 1.96B | |
| -133.22x | - | - | - | 1.24B | |
| -108.33x | - | - | 1.23% | 741M | |
| -97.06x | 1063.3x | -122.11x | -.--% | 802M | |
| Average | -7.12x | 180.06x | 1.08x | 0.57% | 6.23B | |
| Weighted average by Cap. | 42.96x | 44.03x | 35.31x | 0.21% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- RAY B Stock
- Valuation RaySearch Laboratories AB
Select your edition
All financial news and data tailored to specific country editions
